Skip to main content

Year: 2019

PenFed Credit Union and TrueCar Partner with Volvo Car USA to Provide PenFed Members with Preferred Pricing and Incentives on New Volvo Vehicles

The Volvo PenFed Member Offer provides qualified PenFed members preferred pricing and cash incentives toward the purchase of a new Volvo vehiclePenFed members are eligible to receive $1,000 Military Purchase Bonus Cash on eligible 2019 and 2020 model-year Volvo vehicles, in addition to transparent Affinity Program Pricing Preferred Volvo pricing offers are available through January 2, 2020 and are available to any PenFed member who has been a member for at least 30 days.SANTA MONICA, Calif., Dec. 05, 2019 (GLOBE NEWSWIRE) —  PenFed Credit Union, TrueCar and Volvo Car USA have partnered on a private targeted incentive program that provides preferred pricing and other incentives for PenFed members. The Volvo PenFed Member Offer is available now until January 2, 2020 through the PenFed Car Buying Service powered by TrueCar. PenFed...

Continue reading

Canbiola to Present at the 12th Annual LD Micro Main Event on December 10, 2019

HICKSVILLE, NY, Dec. 05, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer and seller of a variety of hemp-derived THC-Free Cannabidiol (CBD) Isolate products such as oils, drops/tinctures, creams, moisturizers, chews, and capsules, announced today that Marco Alfonsi, Chief Executive Officer, and Stan Teeple, Chief Financial Officer, will present at the 12th Annual LD Micro Main Event investor conference on Tuesday, December 10, 2019 at 12:00 PM PST (3:00 PM EST). The conference will be held December 10-12, 2019 at the Luxe Sunset Boulevard Hotel in Los Angeles, California.In addition, Mr. Alfonsi and Mr. Teeple will be available the same day for one-on-one meetings. For more information about the conference or to schedule a one-on-one meeting with...

Continue reading

Val-d’Or Mining Exercises Option

VAL-D’OR, Québec, Dec. 05, 2019 (GLOBE NEWSWIRE) — Val-d’Or Mining Corporation (“Val-d’Or Mining” or the “Company) (TSX-V:VZZ) is pleased to announce that it has acquired a 100% interest in a group of properties located in the Abitibi Greenstone Belt of North-Eastern Ontario and North-Western Québec (the “Properties”). The Properties were acquired on exercise of the option granted to the Company by Golden Valley Mines Ltd. (the “Optionor”) in accordance with the terms of the amended and restated mining option agreement between the Company and the Optionor dated November 28, 2019. The original mining option agreement was previously announced by news release dated April 18, 2017. The option agreement was amended to document, among other things, a waiver of expenditure requirements required in order to maintain the option, acceleration...

Continue reading

NETGEAR® to Present at Upcoming Investor Conference

SAN JOSE, Calif., Dec. 05, 2019 (GLOBE NEWSWIRE) — NETGEAR, Inc. (NASDAQ: NTGR), a global networking company that delivers innovative networking and Internet connected products to consumers and businesses, today announced that it is scheduled to present at the following upcoming investor conference in December 2019.Raymond James 2019 Technology Investors ConferenceDate: Tuesday, December 10, 2019Time: 3:00 pm ETPlace: The Westin New York Grand Central, New YorkThe presentation will be webcast on NETGEAR’s IR website at http://investor.netgear.com/.About NETGEAR, Inc.NETGEAR® (NASDAQ: NTGR) has pioneered advanced networking technologies for homes, businesses, and service providers around the world since 1996 and leads the industry with a broad range of award-winning products designed to simplify and improve people’s lives. By enabling...

Continue reading

American BriVision Initiates Phase II Part I Clinical Trial for ABV-1505 in Adult Attention-Deficit Hyperactivity Disorder (ADHD)

 PDC-1421, the active ingredient of ABV-1505, is being expanded into adult ADHD trials following encouraging Phase II trial results in major depressive disorder (MDD) Phase II Part I trial of ABV-1505 to be conducted at the University of California, San Francisco (UCSF) Medical Center Phase II Part II trial of ABV-1505 is expected to follow Part I and be conducted at UCSF and major medical centers in Taiwan      FREMONT, CA, Dec. 05, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — American BriVision (Holding) Corporation (OTCQB: ABVC) (the “Company”), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced the initiation of a new ABV-1505 Phase II Part I clinical trial, under the U.S. Food and Drug Administration (FDA) clinical protocol code BLI-1008-001,...

Continue reading

Weyland Tech’s CreateApp to Support Launch of Mobile App for Push Interactive’s 1,000,000-Subscriber AstrologyNova

NEW YORK, Dec. 05, 2019 (GLOBE NEWSWIRE) — Weyland Tech, Inc. (OTCQX: WEYL), a leading global Platform-as-a-Service (PaaS) provider of m-Commerce and fintech solutions, is supporting an upcoming launch of a new mobile app on Android and iOS for Push Interactive’s AstrologyNova horoscope community. This announcement follows Weyland Tech announcing last week its plans to acquire Push.“Weyland’s earlier work with Push to support the North American introduction of our CreateApp platform led to this strategic acquisition and now co-developed mobile app,” said Eddie Foong, Weyland’s chief product officer and founder of CreateApp. “The AstrologyNova app has been one of our initial joint projects and a technology testbed for enhancing our mutual platforms as we prepare CreateApp for a major rollout to the U.S. SMB market. This includes...

Continue reading

Entra ASA: Renewed and extended lease contract in Biskop Gunnerus gate 14 in Oslo

Entra has renewed and extended a lease contract with Vitec Software for 2,100 sqm in Biskop Gunnerus gate 14 in Oslo. The lease contract has a duration of five years, starting from April 2020. For further queries please contact: Tore Bakken, EVP Market and Property Development tel: +47 900 40 250, email: tba@entra.no. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. 

Continue reading

Informations relatives au nombre total de droits de vote et d’actions prévues au 30 Novembre 2019

Dénomination sociale de l’émetteur : ERAMET SA10 boulevard de Grenelle75015 Paris632 045 381 RCS PARISInformations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 223-8 II du code de commerce et l’article 223-16 du règlement général de l’Autorité des marchés financiersN° LEI : 549300LUH78PG2MP6N64Nombre de droits de vote exerçables = nombre de droits de vote théoriques – actions privées du droit de vote (auto détention, contrat de liquidité, etc.). Pièce jointeERAMET – Info nombre total de droits de vote au 30.11.2019

Continue reading

Predictive Oncology Confirms Indications of Interest for Skyline Medical Business

MINNEAPOLIS, Dec. 05, 2019 (GLOBE NEWSWIRE) — Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that it has received indications of interest from several parties for the possible acquisition of its Skyline Medical division, which produces and sells the STREAMWAY System for disposal of fluids in medical applications. As previously announced, Predictive Oncology has determined that it will focus its resources on its primary mission of applying artificial intelligence to precision medicine and drug discovery.Skyline Medical’s patented, FDA-approved STREAMWAY System is the first truly continuous, direct-to-drain fluid disposal system designed specifically for medical applications. The division...

Continue reading

Duluth Holdings Inc. Announces Third Quarter Fiscal 2019 Financial Results

MOUNT HOREB, Wis., Dec. 05, 2019 (GLOBE NEWSWIRE) — Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading” or the “Company”) (NASDAQ: DLTH), a lifestyle brand of men’s and women’s casual wear, workwear and accessories, today announced its financial results for the fiscal third quarter ended November 3, 2019.Highlights for the Third Quarter Ended November 3, 2019Net sales increased 12.2% to $119.8 million compared to $106.7 million in the prior-year third quarterGross margin decreased 250 basis points to 54.6% compared to 57.1% in the prior-year third quarterOperating income of $1.3 million compared to operating loss of $2.6 million in the prior-year third quarterNet income of $0.2 million, or $0.01 per diluted share, compared to a net loss of $3.2 million, or $0.10 per diluted share, in the prior-year third quarterAdjusted...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.